Myanmar — Fishery/Seafood Products

← back to leaderboard

Myanmar received 43 FDA import refusals in Fishery/Seafood Products between 2023-Q4 and 2026-Q3. Volume peaked at 7 in 2026-Q2, with the trend rising sharply year-on-year. The most-cited issues are salmonella, imptrhaccp, and mfr insan. No trade baseline is published for this commodity from Myanmar, so no per-$1B rate is shown here.

Of these, 41 were hazard refusals and 2 were paperwork refusals.

Exporting from Myanmar? Get an email when shipments from Myanmar are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

2 2023-Q4 2023-Q4: 2 6 2024-Q1 2024-Q1: 6 1 2024-Q2 2024-Q2: 1 3 2024-Q3 2024-Q3: 3 2 2024-Q4 2024-Q4: 2 4 2025-Q1 2025-Q1: 4 4 2025-Q2 2025-Q2: 4 0 2025-Q3 2025-Q3: 0 1 2025-Q4 2025-Q4: 1 6 2026-Q1 2026-Q1: 6 7 2026-Q2 2026-Q2: 7 7 2026-Q3 2026-Q3: 7

By commodity, last 156 weeks

Commodity Rejections Per $1B US imports Most-cited hazard
Fish-Other 42 salmonella
Shrimp-Prawn 1 no process

Recent rejections